JA
MDCO

JOYN Advisors’s Medicines Co MDCO Stock Holding History

JOYN Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-250
Closed -$5K – 1682
2018
Q4 		$5K Buy
250
+116
+87% +$2.7K ﹤0.01% 1276
2018
Q3 		$4K Sell
134
-2
-1% -$75 ﹤0.01% 1305
2018
Q2 		$5K Buy
136
+122
+871% +$3.96K ﹤0.01% 1170
2018
Q1 		$0 Buy
+14
New +$437 ﹤0.01% 1453

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

JOYN Advisors's MDCO Position: Q1 2019 in Review

JOYN Advisors sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 250 shares — an estimated $5K sold.

JOYN Advisors first reported a position in MDCO in Q1 2018 and held it in 4 quarters. The position peaked at $5K in Q4 2018. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

  • JOYN Advisors reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
  • JOYN Advisors sold 250 Medicines Co shares in Q1 2019, an estimated $5K.
  • JOYN Advisors first reported a position in Medicines Co in Q1 2018 and held it in 4 quarters.
  • JOYN Advisors's Medicines Co position peaked at $5K in Q4 2018.
  • 203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on JOYN Advisors's 13F filing for Q1 2019, filed 9 May 2019.